PCLA Nasdaq Electric Lighting & Wiring Equipment Financials FY2022βFY2025
PicoCELA Inc. had $3.7M of revenue in fiscal 2025, down 30.0% on the year before.
Hi! I read PicoCELA Inc.βs latest annual report (fiscal 2025). Here is what stands out:
Good So-so Weak
Are sales growing?
β30.0%
No. Sales fell 30.0% last year.
Does it make a profit?
β115.0%
No. It lost money last year.
Does profit turn into cash?
β105.1%
No. It spent more cash than it brought in.
How healthy are the accounts?
1 / 8
Weak. It passes 1 of 8 health tests.
Rules of thumb on reported numbers. A starting point, not a recommendation.
Is it selling more, and how much does it keep?
In plain words: Every quarter, companies publish how much they sold and earned. These are the days PicoCELA Inc. did it, and the next one. Share prices often move a lot on those days.
Next results
February 12, 2027
Friday Β· in 109 days
Estimated from the same quarter last year. It will be replaced by the announced date once there is one.
See who else reports that week βKIRA Β· PicoCELA Inc. had $3.7M of revenue in fiscal 2025, down 30.0% on the year before. Its operating margin was β110.4%, down 53.4Β pts: of every 100 in sales, about β110 is left after running the business.
In plain words: Revenue is all the money customers paid. The margins show how many cents of each dollar of sales are left over at each step: after making the product (gross), after running the business (operating) and after everything, tax included (net).
Revenue
Margins, % of revenue
KIRA Β· PicoCELA Inc. lost $4.2M in fiscal 2025.
Loss periods are shown in red.
In plain words: Net income is the profit left after every cost and tax. Earnings per share (EPS) splits that profit across every share, so it shows what one share earned.
Net income
Diluted EPS
How much cash comes in, and where does it go?
KIRA Β· Free cash flow was β$3.8M in fiscal 2025, β105.1% of revenue.
Cash from operations minus capital spending.
In plain words: Profit on paper is not the same as cash in the bank. Free cash flow is the cash left after paying to run and maintain the business: the money it can hand back to shareholders, save or invest.
Free cash flow
Cash from operations vs capital spending
In plain words: Companies hand cash back in two ways: dividends (cash paid to shareholders) and buybacks (buying back their own shares, so each remaining share owns a bigger slice).
Dividends and buybacks
Diluted shares outstanding (annual)
KIRA Β· No open-market insider trades in the last 12 months.
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. βPlanβ marks trades under a pre-arranged Rule 10b5-1 plan.
In plain words: Insiders are the people who run or own a big part of the company. Buying with their own money can signal confidence; selling often has personal reasons, like taxes or diversifying.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Can it carry its debts, and how well does it use its money?
KIRA Β· PicoCELA Inc. has $0.0M more cash than debt.
Cash, debt and the ratios that show how comfortably PicoCELA Inc. can carry it.
In plain words: What the company owns and what it owes. More cash than debt is a cushion for bad times; a lot of debt leaves less room when business slows down.
Cash vs debt (incl. leases)
| Fiscal year end | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Cash and short-term investments | β | $2.9M | $3.2M | $3.6M |
| Debt incl. finance leases | β | $3.1M | $3.3M | $3.6M |
| Debt / equity | β | 0.7x | 1.3x | 1.1x |
| Current ratio | β | 2.8x | 2.2x | 2.1x |
| Quick ratio | β | 2.3x | 1.7x | 1.6x |
| Total assets | β | $7.7M | $8.6M | $7.3M |
| Total liabilities | β | $3.0M | $6.2M | $4.2M |
| Shareholders' equity | $3.2M | $4.7M | $2.5M | $3.2M |
| Net debt (β = net cash) | β | $0.2M | $0.1M | β$0.0M |
KIRA Β· Its return on capital was β100.4%: every 100 invested in the business earned about β100 in a year.
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
In plain words: How much profit the business makes on the money put into it. A higher percentage means each dollar invested works harder.
Return on capital, equity and assets (annual)
KIRA Β· PicoCELA Inc. passes 1 of 8 financial health tests (Piotroski F-score).
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
In plain words: Nine yes/no tests of financial health, one point each. A green tick is a pass: 7 to 9 points is solid, 0 to 3 is weak.
| Test | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Net income is positive | β | β | β | β |
| Cash from operations is positive | β | β | β | β |
| Return on assets rose | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β |
| Debt fell relative to assets | β | β | β | β |
| Current ratio rose | β | β | β | β |
| Share count didn't rise | β | β | β | β |
| Gross margin rose | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β |
| F-score | β / 3 | β / 4 | 4 / 8 | 1 / 8 |
| Accruals ratio | β | 9.9% | β19.3% | β6.9% |
| Altman Z'' | β | β3.55 | β4.98 | β8.19 |
Every number, year by year.
Amounts in USD. Hover a ratioβs name for its definition.
In plain words: Every number we have, year by year. Download it as a spreadsheet if you want to dig deeper.
| Fiscal year | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $5.5M | $4.0M | $5.2M | $3.7M |
| Research and development | $0.3M | $0.5M | $0.3M | $0.2M |
| Operating income | β$0.1M | β$4.5M | β$3.0M | β$4.0M |
| Pretax income | β$0.0M | β$4.6M | β$3.2M | β$4.2M |
| Net income | β$0.0M | β$4.6M | β$3.2M | β$4.2M |
| Diluted EPS | β$0.01 | β$19.33 | β$8.88 | β$4.58 |
| Diluted shares | 0.01B | 0.00B | 0.00B | 0.00B |
| Cash flow | ||||
| Cash from operations | β$0.9M | β$5.3M | β$1.6M | β$3.6M |
| Capital expenditure | $0.0M | $0.1M | $0.1M | $0.2M |
| Free cash flow | β$1.0M | β$5.5M | β$1.7M | β$3.8M |
| Depreciation and amortization | $0.1M | $0.1M | $0.1M | $0.2M |
| Stock-based compensation | β | β | β | $0.0M |
| Balance sheet | ||||
| Cash and short-term investments | β | $2.9M | $3.2M | $3.6M |
| Total debt | β | $3.1M | $3.3M | $3.6M |
| Current assets | β | $6.8M | $6.6M | $6.7M |
| Current liabilities | β | $2.5M | $3.0M | $3.1M |
| Inventory | β | $1.2M | $1.4M | $1.8M |
| Property and equipment, net | β | $0.1M | $0.2M | $0.2M |
| Intangible assets | β | $0.1M | $0.1M | $0.0M |
| Total assets | β | $7.7M | $8.6M | $7.3M |
| Total liabilities | β | $3.0M | $6.2M | $4.2M |
| Shareholders' equity | $3.2M | $4.7M | $2.5M | $3.2M |
| Margins | ||||
| Operating margin | β2.4% | β112.3% | β57.0% | β110.4% |
| EBITDA margin | β1.2% | β110.2% | β54.4% | β105.5% |
| Net margin | β0.8% | β113.3% | β61.2% | β115.0% |
| FCF margin | β17.4% | β135.9% | β33.4% | β105.1% |
| Returns | ||||
| Return on capital | β | β73.6% | β92.6% | β100.4% |
| Return on capital employed | β | β86.3% | β53.1% | β95.9% |
| Return on equity | β1.3% | β115.5% | β89.3% | β148.3% |
| Return on assets | β | β59.3% | β39.1% | β52.5% |
| Return on tangible equity | β1.3% | β99.5% | β131.5% | β133.7% |
| Growth | ||||
| Revenue growth | β | β26.5% | 29.6% | β30.0% |
| Share count change | β | β96.7% | 52.3% | 154.9% |
| Financial health | ||||
| Debt / equity | β | 0.7x | 1.3x | 1.1x |
| Current ratio | β | 2.8x | 2.2x | 2.1x |
| Quick ratio | β | 2.3x | 1.7x | 1.6x |
| Capital allocation | ||||
| Capex / revenue | 0.5% | 3.7% | 2.4% | 5.2% |
| Stock comp / revenue | β | β | β | 1.0% |
| Quality scores | ||||
| Piotroski F-score | β | β | 4.0 | 1.0 |
| Altman Z'' | β | β3.5 | β5.0 | β8.2 |
| Accruals ratio | β | 9.9% | β19.3% | β6.9% |
Source: SEC EDGAR XBRL filings (CIK 0002018462). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. Filed in JPY under US GAAP and converted to US$: income and cash-flow lines at each period's average exchange rate, balance-sheet lines at the period-end rate. For information only β not investment advice. Check the original filings before relying on any figure.
